Differential TLR-Induced cytokine production by human mast cells is amplified by FcɛRI triggering

Clinical and Experimental Allergy

Volumn 45, Issue 4, 2015, Pages 788-796

  Suurmond, J ^a   Dorjee A L ^a   Knol, E F ^b   Huizinga, T W J ^a   Toes, R E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical immunology; IgE; Innate immunity; Mast cells; Toll like receptors

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; ALLERGEN; CYTOKINE; LIGAND;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; NORMAL HUMAN; PRIORITY JOURNAL; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; METABOLISM;

ALLERGENS; ANIMALS; ANTIBODY SPECIFICITY; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; LIGANDS; MAST CELLS; RECEPTORS, IGE; TOLL-LIKE RECEPTORS;

EID: 84925136364     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12509     Document Type: Article

References (25)

1. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004; 4:787-99.
2. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996; 381:77-80.
3. Sutherland RE, Olsen JS, McKinstry A, Villalta SA, Wolters PJ. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 2008; 181:5598-605.
4. Shelburne CP, Nakano H, St John AL et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 2009; 6:331-42.
5. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001; 167:2250-6.
6. Gurish MF, Bryce PJ, Tao H et al. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol 2004; 172:1139-45.
7. Marichal T, Starkl P, Reber LL et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013; 39:963-75.
8. Sykes A, Johnston SL. Etiology of asthma exacerbations. J Allergy Clin Immunol 2008; 122:685-8.
9. Message SD, Laza-Stanca V, Mallia P et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA 2008; 105:13562-7.
10. Gern JE. Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immunol 2000; 105:S497-502.
11. Michel O, Kips J, Duchateau J et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154:1641-6.
12. Trompette A, Divanovic S, Visintin A et al. Allerginicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457:585-8.
13. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006; 107:610-8.
14. Fehrenbach K, Port F, Grochowy G et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. Mol Immunol 2007; 44:2087-94.
15. Saluja R, Delin I, Nilsson GP, Adner M. FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment. PLoS ONE 2012; 7:e43547.
16. Suurmond J, Rivellese F, Dorjée AL et al. Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies. Ann Rheum Dis 2014; doi:10.1136/annrheumdis-2014-205562.
17. Supajatura V, Ushio H, Nakao A et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109:1351-9.
18. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003; 170:1625-9.
19. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6:761-71.
20. Naclerio RM. Pathophysiology of perennial allergic rhinitis. Allergy 1997; 52:7-13.
21. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-51.
22. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
23. Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 2004; 173:5247-57.
24. Yoshioka M, Fukuishi N, Iriguchi S et al. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 2007; 120:452-61.
25. Sumbayev VV, Yasinska I, Oniku AE, Streatfield CL, Gibbs BF. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS ONE 2012; 7:e34259.